cbdMD Inc Cash Flow Conversion Efficiency
cbdMD Inc cash flow conversion efficiency. Based on the latest financial reports, cbdMD Inc (YCBD) has a cash flow conversion efficiency ratio of -0.115x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-704.20K) by net assets ($6.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of cbdMD Inc (2015–2024)
Cash flow conversion efficiency of cbdMD Inc from 2015 to 2024. This chart illustrates how cbdMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View YCBD live share price for real-time trading data and today's change.
cbdMD Inc Cash Flow Conversion Ratio Explained
cbdMD Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
cbdMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of cbdMD Inc ranked by their cash flow conversion efficiency. Also see market cap of cbdMD Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clever Group Corp
VN:ADG
|
N/A |
|
ZINC of Ireland NL
AU:ZMI
|
-0.016x |
|
Capitol Nusantara Indonesia
JK:CANI
|
0.005x |
|
Sidomulyo Selaras Tbk
JK:SDMU
|
0.006x |
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
-0.016x |
|
Kaili Resources Ltd
AU:KLR
|
0.016x |
|
Luminar Technologies
NASDAQ:LAZR
|
0.159x |
|
Syra Health Corp. Class A Common Stock
NASDAQ:SYRA
|
0.576x |
Annual Cash Flow Conversion Efficiency for cbdMD Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of cbdMD Inc from 2015 to 2024. Review cbdMD Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $1.96 Million | $-352.79K | -0.180x | +62.28% |
| 2023-09-30 | $9.03 Million | $-4.30 Million | -0.476x | -0.01% |
| 2022-09-30 | $31.42 Million | $-14.97 Million | -0.476x | -248.57% |
| 2021-09-30 | $103.14 Million | $-14.09 Million | -0.137x | -1.45% |
| 2020-09-30 | $79.18 Million | $-10.66 Million | -0.135x | +67.07% |
| 2019-09-30 | $37.60 Million | $-15.38 Million | -0.409x | -2.87% |
| 2018-09-30 | $14.02 Million | $-5.57 Million | -0.398x | +12.15% |
| 2017-09-30 | $5.15 Million | $-2.33 Million | -0.452x | -104.57% |
| 2016-09-30 | $-292.73K | $-2.90 Million | 9.898x | +840.59% |
| 2015-09-30 | $1.28 Million | $-1.71 Million | -1.336x | -- |
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more